These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 20627731

  • 1. Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke.
    Kurzepa J, Bielewicz J, Grabarska A, Stelmasiak Z, Stryjecka-Zimmer M, Bartosik-Psujek H.
    J Clin Neurosci; 2010 Aug; 17(8):997-9. PubMed ID: 20627731
    [Abstract] [Full Text] [Related]

  • 2. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
    Isahaya K, Yamada K, Yamatoku M, Sakurai K, Takaishi S, Kato B, Hirayama T, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):102-7. PubMed ID: 21215657
    [Abstract] [Full Text] [Related]

  • 3. Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke.
    Cojocarui IM, Cojocaru M, Sapira V, Socoliuc G, Hertea C, Paveliu S.
    Rom J Intern Med; 2012 Feb; 50(2):155-8. PubMed ID: 23326959
    [Abstract] [Full Text] [Related]

  • 4. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
    Worthmann H, Tryc AB, Goldbecker A, Ma YT, Tountopoulou A, Hahn A, Dengler R, Lichtinghagen R, Weissenborn K.
    Cerebrovasc Dis; 2010 Feb; 30(1):85-92. PubMed ID: 20484906
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M, Furie KL, Koroshetz WJ, Lee H, Barron M, Lederer M, Wang X, Zhu M, Sorensen AG, Lo EH, Kelly PJ.
    Neurology; 2006 May 23; 66(10):1550-5. PubMed ID: 16717217
    [Abstract] [Full Text] [Related]

  • 8. [Correlation between serum MMP-2 and MMP-9 in patients with acute myocardial infarction before and after PCI].
    Dai F, Xiao GL, Pan J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug 23; 25(8):716-8. PubMed ID: 19664397
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY, Wu MS, Chiang EP, Chen YJ, Chen CJ, Chi NH, Shih YT, Chen GH, Lin JT.
    Clin Cancer Res; 2007 Apr 01; 13(7):2054-60. PubMed ID: 17404086
    [Abstract] [Full Text] [Related]

  • 11. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kähäri VM, Pyrhönen S.
    Clin Cancer Res; 2005 Jul 15; 11(14):5158-66. PubMed ID: 16033831
    [Abstract] [Full Text] [Related]

  • 12. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
    Sliwowska I, Kopczyński Z.
    Wiad Lek; 2007 Jul 15; 60(5-6):241-7. PubMed ID: 17966888
    [Abstract] [Full Text] [Related]

  • 13. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
    Guo M, Cox B, Mahale S, Davis W, Carranza A, Hayes K, Sprague S, Jimenez D, Ding Y.
    Neuroscience; 2008 Jan 24; 151(2):340-51. PubMed ID: 18160227
    [Abstract] [Full Text] [Related]

  • 14. Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke.
    Sobrino T, Pérez-Mato M, Brea D, Rodríguez-Yáñez M, Blanco M, Castillo J.
    J Neurosci Res; 2012 Sep 24; 90(9):1788-93. PubMed ID: 22513751
    [Abstract] [Full Text] [Related]

  • 15. Effect of arundic acid on serum S-100beta in ischemic stroke.
    Pettigrew LC, Kasner SE, Gorman M, Atkinson RP, Funakoshi Y, Ishibashi H, Arundic Acid (ONO-2506) Stroke Study Group.
    J Neurol Sci; 2006 Dec 21; 251(1-2):57-61. PubMed ID: 17092520
    [Abstract] [Full Text] [Related]

  • 16. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke.
    Wunderlich MT, Lins H, Skalej M, Wallesch CW, Goertler M.
    Clin Neurol Neurosurg; 2006 Sep 21; 108(6):558-63. PubMed ID: 16457947
    [Abstract] [Full Text] [Related]

  • 17. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.
    Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T.
    Surg Neurol; 2009 Nov 21; 72(5):476-80; discussion 480. PubMed ID: 19147196
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V.
    Am Heart J; 2008 Jul 21; 156(1):85-91. PubMed ID: 18585501
    [Abstract] [Full Text] [Related]

  • 19. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
    Chung TW, Kim JR, Suh JI, Lee YC, Chang YC, Chung TH, Kim CH.
    J Gastroenterol Hepatol; 2004 May 21; 19(5):565-71. PubMed ID: 15086601
    [Abstract] [Full Text] [Related]

  • 20. Homocysteine and lipoprotein (a) correlation in ischemic stroke patients.
    Dhamija RK, Gaba P, Arora S, Kaintura A, Kumar M, Bhattacharjee J.
    J Neurol Sci; 2009 Jun 15; 281(1-2):64-8. PubMed ID: 19285692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.